Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Dental degree wikipedia , lookup
Dental hygienist wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Scaling and root planing wikipedia , lookup
Focal infection theory wikipedia , lookup
Remineralisation of teeth wikipedia , lookup
Periodontal disease wikipedia , lookup
Special needs dentistry wikipedia , lookup
Earn 2 CE credits This course was written for dentists, dental hygienists, and assistants. Oral Manifestations of Systemic Disease A Peer-Reviewed Publication Written by Jeff Burgess, DDS, MSD Abstract Mucosal ulceration, dental disease and other tooth abnormalities, oral soft tissue tumors, periodontal disease, bone pathology, and orofacial pain may be directly related to or confounded by underlying systemic disease. An understanding of the relationship between systemic disease and oral pathology is important with respect to establishing the diagnosis and determining the complexity of subsequent management. For example, dental caries that is confounded by nutritional deficiency or psychological problems such as bulimia or anorexia, or a medical problem that directly or indirectly (via medication use) causes xerostomia or dry mouth, or a medical condition that alters the patient’s ability to maintain appropriate oral hygiene may need to be managed using a comprehensive strategy that takes into account the underlying medical issue as well as the dental issues. This course reviews such problems and their impact on oral conditions. Publication date: July 2013 Expiration date: June 2016 Educational Objectives: At the end of this educational activity, participants will be able to: 1. Discuss the complexity of the relationship between systemic disease and various oral conditions. 2. Identify the different oral manifestations associated with specific systemic diseases. 3. Differentiate between potential systemic diseases associated with some specific oral conditions such as ulceration. 4. Have improved diagnostic skills in relation to the connection between systemic disease and oral pathology. Author Profile Jeff Burgess, DDS, MSD, (Retired) Clinical Assistant Professor, Department of Oral Medicine, University of Washington School of Dental Medicine; (Retired) Attending in Pain Center, University of Washington Medical Center; (Retired) Private Practice in Hawaii and Washington; Director, Oral Care Research Associates. He can be reached at jeffreyaburgess@ hotmail.com . Author Disclosure Jeff Burgess, DDS, MSD, has no commercial ties with the sponsors or providers of the unrestricted educational grant for this course. Supplement to PennWell Publications PennWell designates this activity for 2 Continuing Educational Credits Dental Board of California: Provider 4527, course registration number CA# 02-4527-13079 “This course meets the Dental Board of California’s requirements for 2 unit of continuing education.” The PennWell Corporation is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing dental education programs of this program provider are accepted by the AGD for Fellowship, Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from (11/1/2011) to (10/31/2015) Provider ID# 320452. This educational activity was developed by PennWell’s Dental Group with no commercial support. This course was written for dentists, dental hygienists and assistants, from novice to skilled. Educational Methods: This course is a self-instructional journal and web activity. Provider Disclosure: PennWell does not have a leadership position or a commercial interest in any products or services discussed or shared in this educational activity nor with the commercial supporter. No manufacturer or third party has had any input into the development of course content. Requirements for Successful Completion: To obtain 2 CE credits for this educational activity you must pay the required fee, review the material, complete the course evaluation and obtain a score of at least 70%. CE Planner Disclosure: Heather Hodges, CE Coordinator does not have a leadership or commercial interest with products or services discussed in this educational activity. Heather can be reached at [email protected] Educational Disclaimer: Completing a single continuing education course does not provide enough information to result in the participant being an expert in the field related to the course topic. It is a combination of many educational courses and clinical experience that allows the participant to develop skills and expertise. Scientific Integrity Statement: Information shared in this CE course is developed from clinical research and represents the most current information available from evidence based dentistry. Registration: The cost of this CE course is $49.00 for 2 CE credits. Cancellation/Refund Policy: Any participant who is not 100% satisfied with this course can request a full refund by contacting PennWell in writing. Educational Objectives At the end of this educational activity, participants will be able to: 1. Discuss the complexity of the relationship between systemic disease and various oral conditions. 2. Identify the different oral manifestations associated with specific systemic diseases. 3. Differentiate between potential systemic diseases associated with some specific oral conditions such as ulceration. 4. Have improved diagnostic skills in relation to the connection between systemic disease and oral pathology. Abstract Mucosal ulceration, dental disease and other tooth abnormalities, oral soft tissue tumors, periodontal disease, bone pathology, and orofacial pain may be directly related to or confounded by underlying systemic disease. An understanding of the relationship between systemic disease and oral pathology is important with respect to establishing the diagnosis and determining the complexity of subsequent management. For example, dental caries that is confounded by nutritional deficiency or psychological problems such as bulimia or anorexia, or a medical problem that directly or indirectly (via medication use) causes xerostomia, or a medical condition that alters the patient’s ability to maintain appropriate oral hygiene may need to be managed using a comprehensive strategy that takes into account the underlying medical issue as well as the dental issues. This course reviews such problems and their impact on oral conditions. Introduction Numerous orofacial conditions are associated with systemic disease. The most serious problems of concern to dental professionals include caries, oral ulcers, mucosal erythema and sloughing, gingival bleeding and hypertrophy, soft tissue exophytic masses, dry mouth, facial pain, movement disorders, tooth abnormalities, abnormal dental wear, tooth/mucosal discoloration, developmental and bone pathology. This review focuses on the systemic conditions that may cause or contribute to the above oral problems. Caries Dental caries may be caused or aggravated by a number of systemic diseases via their impact on the three primary factors that are thought to contribute to dental caries: the presence of bacteria and biofilm known to cause caries, the availability of a consistent food source (e.g. sugar) for these bacteria, and oral hygiene. Other factors such as genetics (e.g. tooth development, matrix metalloproteinases) and the use of medications in the treatment of systemic disease (e.g. affect on salivation) may also play a role in the development of caries. A very complex relationship exists between these factors with respect to caries initiation in both primary and adult teeth. It is known that any perturbation of the oral environment can increase the potential for the development of dental caries. For example, in a study on the relationship between dental caries and nutritional status, snack foods, and the consumption of sugar-sweetened beverages in schoolchildren in Thailand, it was found that malnutrition as well as food intake habits at bedtime were significantly related to the development of dental caries in the primary dentition.1 In addition to malnutrition, other conditions impacting diet are also cited in the literature as associated with the development of caries. These include medical (e.g. diabetes) and psychological (e.g. drug abuse, bulimia, etc.) problems. The following subsections detail some of the specific systemic problems that are suspected of impacting the development of caries. Diabetes In animal models, a number of studies suggest that rapid progressive caries is associated with chemically induced hyperglycemia.2,3 In contrast to the animal studies, at least one systematic review of the literature questions the scientific validity of a causative link between caries and diabetes in humans.4 The authors of this review suggest that because multiple studies report variable caries experiences between subjects with and without diabetes (e.g. increased, decreased, and similar experiences), that the evidence is, at present, insufficient to determine if a true risk-relationship actually exists in humans. Drug Abuse Multiple studies have linked the abuse of drugs to the development of dental caries.5-8 The problem has been identified in many countries throughout the world.9-12 One of the drugs that has been most recently studied in relation to caries is methamphetamine.13 The street description of ‘meth mouth’ is not without merit as this particular drug and its abuse appears to be associated with considerable tooth decay as well as other oral problems such as periodontal disease. Some evidence suggests that salivary pH may be the reason the drug contributes to dental caries.14 The abuse of narcotics and alcohol has also been associated with an increased risk of caries. However, in at least one comparative study, alcohol abuse was less likely than ‘drug’ abuse to lead to the development of caries. The combination of alcohol and drug abuse (which included self-reported use of not only heroin and methadone but also cannabis, benzodiazepines, and cocaine) led to the greatest caries risk (38% increased risk).15 The authors of this study speculate that the lower rate in persons abusing alcohol, and particularly those that drink beer may be related to the effect of increased fluoride consumption which is an ingredient in beer. 2www.ineedce.com The caries risk from narcotics is not just related to street use. A recent case report describes the development of rampant caries from the abuse of oral transmucosal fentanyl citrate lozenges which are used for the oral management of breakthrough cancer pain.16 Presumably caries risk associated with drug use is behavioral in nature and relates to neglect of oral hygiene. Smokeless tobacco use has also been linked to dental caries, specifically root caries.17 With respect to cannabis use, one study found that subjects using this drug excessively had significantly greater smooth surface caries than controls. The authors speculate that this was related to the drugs effect on salivation (hyposalivation during use) and on subsequent post-smoking sugar intake (from the ‘munchies’).18 In addition, as noted previously, any medication that reduces salivation has the potential to increase the risk of caries, particularly if it is used over a prolonged period of time.19 However, other than anecdotes, there is little documented research assessing the link between the commonly used drugs that cause xerostomia and caries progression. In one animal study chronic administration of clonidine20 and propranolol21 was found to increase caries in rats. Other drugs causing dry mouth that are utilized by patients that could cause caries include antihistamines, anti-depressants such as Elavil® (amitriptyline), Asendin® (amoxapine), Anafranil® (clomipramine), Remeron® (mirtazapine) and Aventyl® or Pamelor® (nortriptline), and Detrol® which is commonly used to treat incontinence. Bulimia and Anorexia Bulimia, a condition associated with repeated vomiting, has been connected to the development of dental caries in both men and women.22 This is presumed to be related to the fact that patients who chronically vomit, bathe their teeth in stomach acid during this purging behavior. In addition to bulimia, anorexia is another psychological condition that may include vomiting and has also been associated with an increase in dental caries. However in a recent systematic review of the literature assessing the orofacial manifestations of these conditions, including caries, the authors suggest that the development of caries in patients with eating disorders may not be an automatic sequalae of these abnormalities.23 Nonetheless, in otherwise healthy patients with good oral hygiene but with unusual smooth surface lesions or rampant caries, eating disorders should be considered as a potential cause of the disease. Caries activity in this group of patients may also be confounded by general diet and oral hygiene as well as salivary gland disturbance. Medical Conditions Reducing Hygiene Behavior Any medical condition that contributes to a reduction in oral hygiene can increase the potential for the development www.ineedce.com of dental caries. Diseases which reduce coordination, limit cognitive activity, or involve significant physical or mental disability have the potential to facilitate dental disease, including caries, and subsequent tooth loss.24 Finally, there is limited evidence that genetic factors such as a mutant allele for MMP13 (one of the genes that is responsible for producing a matrix metalloproteinase) may contribute in some manner to the etiology of dental caries.25 Oral Ulcers The systemic conditions that can cause oral ulceration include infection (e.g. syphilis,26, 27 tuberculosis,28 HIV/ AIDS,29,30 viral infection including herpangina and primary herpetic stomatitis including herpes simplex virus causality (HSV-1 or 2),31 candida and other fungal organisms (e.g. mucormycosis or histoplasmosis,32-35 autoimmune disease (e.g. lupus,36,37 pemphigus and paraneoplastic pemphigus,38,39 lichen planus,40 inflammatory bowel disease,41 thyroid disease,44 malignancy/haematologic disease,45,46 cyclic neutropenia,47 allergy and other drug reactions,48-50 and vascular inflammatory disease.51 Oral ulceration may also be associated with organ transplants and the medications used to manage rejection or treat other diseases (e.g. thyroid disease),52 liver transplant,53 or renal transplant.54 Nutritional deficiencies are also associated with intraoral ulceration.55,56 Oral ulceration has also been reported with hypogammaglobulinemia.57 Generally the clinical presentation of oral ulcers is not specific enough to allow identification of the underlying pathology in cases involving systemic disease. There are, however, several clinical features that may be helpful in guiding the clinician with respect to the differential diagnosis in these cases. These include ulcer location, duration, reoccurrence, depth, number, size, scarring, and non-healing. Lesion Location Lesions associated with primary herpetic stomatits occur not only on the intraoral mucosa of the cheek, tongue, palate, and posterior pharynx, but also on the attached gingiva. This is not a typical presentation that is associated with most other oral ulcerative diseases and thus can be used to help differentiate between non-viral and viral etiology. Lesion Duration Viral lesions and aphthous ulcers typically persist for 10-14 days and heal with complete resolution. In contrast, lesions associated with Behcet’s disease may persist for up to four to six weeks. Ulcers related to underlying neoplasm, a compromised immune system, or nutritional deficiency persist for a much longer period of time. Lesion Reoccurrence Ulceration reoccurring on the attached gingiva is likely to represent secondary (or reoccurring) HSV-1 or HSV-2. 3 Lesion Depth Deep cratering of the oral mucosa is typical of the ulcers associated with Behcet’s disease and HIV/AIDS. However, lesions associated with major aphthous, tuberculosis and syphilis may also be relatively deep. Deep tongue lesions may also be associated with amyloidosis58 and malignancy. Number of Lesions Multiple ulcers clustered throughout the mouth suggest viral etiology (e.g. herpes zoster, primary herpetic stomatitis, or herpangina). The Size of the Lesion Large (>1cm or greater) oral ulcers are most typically seen with erythema multiforma, allergy, benign mucous membrane pemphigoid (BMMP) disease, pemphigus vulgaris, erosive lichen planus, radiation mucositis or mucositis associated with chemotherapy and lesions associated with severe immunosuppression or uremic stomatits. Large lesions are not typically observed with viral infection although sometimes small lesions will coalesce to form larger ulcers.59 Post lesion scarring Ulceration occurring with Bechet’s disease occurs with posthealing scarring. Typically patients with this condition will have areas of mucosa that are scarred from past episodes. Non-healing ulcers These are most commonly found with malignancy. Gingival Bleeding, Hyperplasia, Discoloration Gingival Bleeding Systemic conditions that can cause gingival bleeding include some of those that also cause ulceration such as benign mucous membrane pemphigoid (BMMP), pemphigus, lupus erythematosis, leukemia, and erythema multiforme. Other conditions such as uncontrolled diabetes,60 Crohn’s disease (which can cause gingival hyperplasia as well as erythema and bleeding),61 and idiopathic thrombocytopenia62,63 have also been linked to gingival bleeding. In addition to the above, what is termed hormonal gingivitis, a condition that can occur with pregnancy or disease associated with pregnancy, can also cause generalized gingival erythema and bleeding.64-66 Several medications utilized in the management of a number of systemic conditions can cause gingival erythema and bleeding. These include: Trileptal®,68 anticoagulant drugs such as Coumadin®, warfarin or heparin and chemotherapeutic agents such as methotrexate and 5-fluorouracil. A complete list of the chemotherapy agents that can cause mucositis and gingival as well as mucosal bleeding can be found at: http://www.webmd.com/oral-health/guide/ oral-side-effects-of-medications?page=2. Non-steroidal anti-inflammatory drugs, including aspirin may also cause gingival bleeding if used over a prolonged period of time. A number of herbal medicines may interact with non-herbal medications (e.g. the anticoagulants) to increase the potential for gingival bleeding including ginkgo biloba, dong quai, and danshen.69 Other herbal preparations associated with gingival bleeding include ginger, ginseng, garlic, and papaya.70 Gingival Hyperplasia Specific classes of drugs including the immunosuppressants, calcium channel blockers, and anticonvulsants that are used in the treatment of a variety of medical conditions can induce gingival hyperplasia.71, 72 The medications most frequently cited as problematic for abnormal gingival growth include;73 immunosuppressants, calcium channel blockers, and antiepileptic drugs. Gingival Discoloration Gingival discoloration (other than erythema) may be a sign of Addison’s disease (primary hypoadrenocorticism), silver poisoning, primary or metastatic malignancy (melanoma), Kaposi’s sarcoma (with or without associated AIDS), hereditary hemorrhagic telangiectasia, and Peutz-Jeghers syndrome (lip lesions). Intraoral Soft Tissue Tumors General medical conditions that can cause intraoral soft tissue tumors include parathyroid disease (e.g. primary hyperparathyroidism or hyperparathyroidism secondary to an adenoma or carcinoma of a parathyroid gland - Brown’s tumor), malignant acanthosis nigricans (hyperplastic, pebbly lesions on the lips), immunosuppression (squamous papillomas), metastatic neoplasms (typically from the breast, prostate, thyroid, lung), amyloidosis secondary to multiple myeloma (pebbly lesions of the lip and cheek). Some of the other systemic conditions that can cause single or multiple exophytic papules, tissue enlargement, or other growths include; chronic granulomatous disease (Crohn’s disease) (which results in granulomatous gingival enlargement, cobblestone or corrugated labial mucosa), lymphoma, syphilis (ulcer plus atypical clinical presentations in AIDS), end stage kidney disease with dialysis (causes furred tongue); lymphangioma (results in a pebbly mucosal surface).74-88 Dry Mouth Any systemic disease that affects the major or minor salivary glands via direct disease involvement or secondarily as a consequence of medication use, radiation, or surgical trauma can cause dry mouth or xerostomia. Those systemic conditions capable of impacting the salivary glands include:89-93 Sjogren’s disease, chronic renal failure (CRF), 4www.ineedce.com other autoimmune diseases (rheumatoid arthritis, seronegative spondyloarthritis, connective tissue disease, systemic lupus erythematosis), non-Hodgkin lymphoma, diabetes, Parkinson’s disease, HIV/AIDS, psychological problems (anxiety disorders and depression), stroke and Alzheimer’s disease, anemia, cystic fibrosis, and other conditions such as head trauma with nerve damage and chemo or radiation therapy for head and neck cancer. Classes of medications used to treat systemic diseases capable of causing dry mouth include:94 antihistamines, antipsychotics, diuretics, chemotherapeutic agents, migraine medications, anticholinergic/antispasmodic agents, antidiarrhetics, analgesics – antinflammatory type, narcotic analgesics, anti-acne, anti-anxiety medications, anticonvulsants, antihypertensives, anti-nausea and anti-emetic medications, anti-parkinsonian drugs, bronchodilators, muscle relaxants, and other drugs such as cannabis. Dry mouth can occur as a secondary effect of treatment in patients using C-pap for sleep apnea and consequent to the use of COPD inhalers.95 Jaw movement disorders Orofacial Pain Painful jaw movement Movement of the jaw may be limited by fibromyalgia, tetanus, tumor, and dystonia associated with Behcet’s disease. Pain in the region of the mouth and face may be caused by a number of systemic problems. It is not within the purview of this course to extensively review the clinical pain characteristics of the following conditions. However several references are listed for additional review.96, 97 Below are several systemic conditions that can cause orofacial pain: Cardiac disease (e.g. myocardial infarction, angina) Thyroid disease (e.g. thyroiditis) Sinus disease (e.g. acute and chronic sinusitis) Autoimmune disease (e.g. rheumatoid arthritis, lupus, scleroderma) Secondary trigeminal neuralgia (e.g. from tumors such as meningioma, epidermoid tumor, acoustic neurinoma, metastatic tumor, brain stem glioma; vascular lesions such as basilar artery or cavernous sinus aneurysm; connective disease such as scleroderma; Paget’s disease; syphilis; or toxins; MS) Craniofacial pain of musculoskeletal origin (e.g. TMD, TMJ osteoarthritis, bone infection or primary or metastatic tumor) Infection (e.g. otitis media, infection secondary to immunosuppression) Sickle cell disease (sickle cell arthropathy) Vascular inflammatory conditions (e.g. giant cell arteritis, temporal arteritis, Systemic Lupus Erythematosus) Psychological abnormality (e.g. somatoform disorder, pain of psychological origin in the head or face) Medication neurotoxicity (e.g. vincristine) Suboccipital or cervical nerve or muscle problems Diabetes www.ineedce.com Jaw movement can be altered by several medical conditions affecting the musculature, nervous system, vascular system, or the bones of the cranium or mandible. Movement disorders include opening stiffness, opening difficulty, painful movement, and unintentional movement. The conditions that should be considered in the differential diagnosis related to systemic disease for the above jaw movement problems are listed below.98-102 Jaw opening stiffness Jaw opening stiffness can be caused by scleroderma, fibromyalgia, muscular dystrophy, and multiple sclerosis (MS). Opening difficulty Difficulty in opening the jaw may result from infection (including the cephalic form of tetanus), poisoning, neurologic disease, psychogenic abnormality, tumor, substance abuse, dystonia, radiation induced trismus, ‘locked-in’ syndrome, brain stem lesions, idiopathic inflammatory myopathies. Intermittent unintentional movement Additional jaw movement abnormality including intermittent unintentional movement can result from Parkinson’s disease, epilepsy, dystonia, nocturnal paroxysmal dystonia, serotonin syndrome, and substance abuse. Tooth Morphologic Abnormality Dental problems associated with systemic disease include excessive tooth wear (from bulimia, anorexia, neurologic disease, psychological problems, genetic disorders),114-120 developmental (genetic) abnormalities causing malformed or excessive or impacted teeth, discoloration (from medication use), and tooth root resorption (bulimia, gastroesophageal reflux disease, excessive soft drink consumption associated with obesity, diabetes, drug abuse, salivary gland agenesis, and high blood pressure).103-113 Tooth and Mucosal Discoloration Dental discoloration Dental discoloration can arise from the treatment of systemic infection with tetracycline and tetracycline-derived broad spectrum antibiotics. The result is permanent if the drugs are used during development of the teeth and bone as they are incorporated into the dental and enamel structure. Tissues affected include the teeth, bone, and cartilage. Both primary and permanent teeth are susceptible to discoloration which can range from grey to brown or be yellow. Minocycline hydrochloride application during 5 growth and development of bone leads to black or green tooth roots and a blue-gray darkening of the crowns of the permanent teeth. Staining may also occur in erupted permanent teeth from minocycline and within the mucosa of the palate.121-124 Environmental exposure to a number of elements has also been associated with discoloration of teeth. These include silver, iron, and manganese which stain black; mercury and lead dust which stains the teeth blue-green; copper and nickel stain blue to blue/green, and chromic acid which can stain the teeth deep orange.125, 126 Excessive fluoride during development tends to mottle the color of enamel.127 In addition to the above causes of tooth discoloration, neonatal sepsis has also been associated with emergence of ‘green teeth’.128 Mucosal discoloration Mucosal discoloration can be indicative of systemic disease. A large number of conditions can cause varying types of mucosal discoloration. The following are systemic problems that are known to cause mucosal discoloration and the specific type of discoloration that has been described for each condition.129-131 Minocycline is associated with a palatal ring. Kaposi sarcoma (KS) is associated with multiple red lesions within the mucosa, Addison’s disease results in hyperpigmentation of the mucosa, melanoma results in a diffuse or more discrete solitary blue black tissue, thrombocytopenic purpura/leukemia and hemophilia are characterized by mucosal petechiae, pernicious anemia causes tongue discoloration, infection (such as infectious mononucleosis) is associated with petechiae on the palate. Generalized redness of the oral mucosa is associated with a number of systemic diseases including: pemphigus, erosive lichen planus, radiation necrosis, mucositis, candidosis secondary to immunosuppression, allergy, erythema multiforme, polycythemia, Crohn’s disease, epidermolysis bullosa, viral infection, leukemia, uremic stomatitis, and vitamin B deficiency Bone Pathology Radiolucencies associated with the pericoronal or follicular spaces adjacent to the teeth are not uncommon. However systemic disease that can cause this type of bone loss is rare. Those conditions that have been linked to lesions associated with unerupted teeth include Ewing’s sarcoma, histiocytosis X, pseudotumor of hemophilia, and salivary gland tumors. The diseases that can cause unilocular or multilocular radiolucency or radiolucency in the maxilla or mandible not linked to the dentition include metastatic carcinoma, giant cell tumor resulting from hyperparathyroid disease or neurofibromatosis type 1, Burkitt’s lymphoma, chondrosarcoma, eosinophilic granuloma, fibrous dysplasia, cherubism, Ewing’s sarcoma, Langerhan’s cell disease (idiopathic histiocytosis), malignant lymphoma of bone, multiple myeloma, neuroblastoma, neurosarcoma, sarcoidosis, tuberculosis, and scleroderma. For a complete review of disease that can cause bone pathology the reader is referred to the authoritarian texts that are provided as references. The differential diagnosis is refined clinically by the patient’s gender, age, predominant jaw and region of the jaw where the lesion is located, the type of lesion (unilocular or multilocular) and the configuration of the lesion’s borders (e.g. well defined or diffuse/ill-defined), the patient’s symptom history (e.g. presence or absence of pain, dyesthesia/paresthesia,), and examination findings (e.g. localized swelling, gingival involvement, tooth mobility, tooth vitality). Other important considerations include serum chemistries, general symptoms, and bone biopsy. Another condition involving the jaw bones is osteonecrosis caused by the use of bisphosphonates as treatment for advanced forms of cancer.133 Bone resorption of the mandibular angle has been associated with progressive systemic sclerosis. A generalized rarefaction of the jaw bones may also result from nutritional abnormality such as calcium deficiency (causing osteomalacia or ‘rickets’) or vitamin C deficiency as well as the hereditary hemolytic anemias such as thalassemia and sickle cell anemia. Leukemia can also cause rarefaction of the skull and jaw ramus. In the early stages of Paget’s disease (osteitis deformans) rarefaction and bone resorption are associated with radiographic radiolucency and in the later stage when there is fibrous deposition the bones take on a ‘cotton-wool’ appearance when viewed radiographically. The temporomandibular joints may be affected by connective tissue diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and arthritis associated with lupus as well as systemic cancer with metastasis. Gout may also affect the TMJ. Dermatomyositis has been reported to be associated with condylar resorption.141-146 Conclusion The effect of systemic health on oral disease is well documented and includes soft and hard tissue abnormality and pathology. The diagnosis of oral pathology by dental professionals may contribute towards the discovery of systemic disease. Regardless of which way the arrow points, the complexity of management of oral disease associated with systemic disease is likely to be confounded by the connection between the two and successful management warrants an understanding of both problems. Further Reading Section on Pain: 1. Surgical management of pain. Editor Kim J Burchiel, Thieme, New York, 2002. Chapter 20, Jeffrey A Burgess, p 276-287. 2. Neurosurgical management of pain. Editors Richard B North, Robert M. Levy, Springer, New York, 1996, Chapter 7: Facial and Cranial Pain; Kim J Burchiel and Jeffrey A Burgess. 6www.ineedce.com Sections on Bone, Tooth, and Mucosal Pathology: 1. Differential Diagnosis of Oral Lesions. Editors Norman K Wood and Paul W Goaz. C.V. Mosby Company, St Louis, Second edition. 1980. 2. Tumors of the Head and Neck; Clinical and Pathological Considerations. 2nd Ed. John G Batsakis, Williams and Wilkins, Baltimore, 1982. 3. Oral and Maxillofacial Pathology. Editors Brad W Neville, Douglas D Damm, Carl M Allen, Jerry E Bouquot, W.B. Saunders Company, Philadelphia, 1995. References 1. Lueangpiansamut J, Chatrchaiwiwatana S, Muktabhant B, Inthalohit W. Relationship between dental caries status, nutritional status, snack foods, and sugar-sweetened beverages consumption among primary schoolchildren grade 4-6 in Nongbua Khamsaen school, Na Klang district, Nongbua Lampoo Province, Thailand. J Med Assoc Thai. Aug 2012;95(8):1090-7. [PMID: 23061315]. 2. Nakahara Y, Sano T, Kodama Y, Ozaki K, Matsuura T. Alloxan-induced hyperglycemia causes rapid-onset and progressive dental caries and periodontitis in F344 rats. Histol Histopathol. Oct 2012;27(10):1297-306. [PMID: 22936448]. 3. Sano T, Matsuura T, Ozaki K, Narama I. Dental caries and caries-related periodontitis in type 2 diabetic mice. Vet Pathol. 2011/03;48(2):506-12. 4. Taylor GW, Manz MC, Borgnakke WS. Diabetes, periodontal diseases, dental caries, and tooth loss: a review of the literature. Compend Contin Educ Dent. Mar 2004;25(3):179-84, 186-8, 190; quiz 192. [PMID: 15641324]. 5. Gupta T, Shah N, Mathur VP, Dhawan A. Oral health status of a group of illicit drug users in Delhi, India. Community Dent Health. Mar 2012;29(1):49-54. [PMID: 22482250]. 6. Ma H, Shi XC, Hu DY, Li X. The poor oral health status of former heroin users treated with methadone in a Chinese city. Med Sci Monit. 2012/04;18(4):1-5. 7. Ravenel MC, Salinas CF, Marlow NM, Slate EH, Evans ZP, Miller PM. Methamphetamine abuse and oral health: a pilot study of “meth mouth”. Quintessence Int. Mar 2012;43(3):229-37. [PMID: 22299123]. 8. Turkyilmaz I. Oral manifestations of “meth mouth” a case report. J Contemp Dent Pract. 2010/01;11(1):E073-80. 9. Carter EF. Dental implications of narcotic addiction. Aust Dent J. Aug 1978;23(4):308-10. [PMID: 282833]. 10. Sakki TK, Knuuttila ML, Vimpari SS, Kivelä SL. Lifestyle, dental caries and number of teeth. Community Dent Oral Epidemiol. Oct 1994;22(5 Pt 1):298-302. [PMID: 7813180]. 11. Scheutz F. Dental health in a group of drug addicts attending an addiction-clinic. Community Dent Oral Epidemiol. 1984/02;12(1):23-8. 12.Reece AS. Dentition of addiction in Queensland: poor dental status and major contributing drugs. Aust Dent J. Jun 2007;52(2):144-9. [PMID: 17687962]. 13. Morio KA, Marshall TA, Qian F, Morgan TA. Comparing diet, oral hygiene and caries status of adult methamphetamine users and nonusers: a pilot study. J Am Dent Assoc. Feb 2008;139(2):171-6. [PMID: 18245685]. 14.Ravenel MC, Salinas CF, Marlow NM, Slate EH, Evans ZP, Miller PM. Methamphetamine abuse and oral health: a pilot study of “meth mouth”. Quintessence Int. Mar 2012;43(3):229-37. [PMID: 22299123]. 15. Dasanayake AP, Warnakulasuriya S, Harris CK, Cooper DJ, Peters TJ, Gelbier S. Tooth decay in alcohol abusers compared to alcohol and drug abusers. Int J Dent. 2010;2010:786503. [PMID: 20379366]. 16.Mandel L, Carunchio MJ. Rampant caries from oral transmucosal fentanyl citrate lozenge abuse. J Am Dent Assoc. Apr 2011;142(4):406-9. [PMID: 21454846]. www.ineedce.com 17. Winn DM. Tobacco use and oral disease. J Dent Educ. Apr 2001;65(4):306-12. [PMID: 11336115]. 18.Schulz-Katterbach M, Imfeld T, Imfeld C. Cannabis and caries--does regular cannabis use increase the risk of caries in cigarette smokers?. Schweiz Monatsschr Zahnmed. 2009;119(6):576-83. 19. Samec T, Amaechi BT, Battelino T, Krivec U, Jan J. Influence of anti-asthmatic medications on dental caries in children in Slovenia. Int J Paediatr Dent. May 18 2012;[PMID: 22607111]. 20. Watson GE, Pearson SK, Bowen WH. The effect of chronic clonidine administration on salivary glands and caries in the rat. Caries Res. Mar-Apr 2000;34(2):194-200. [PMID: 10773639]. 21. O’Connell AC, Van Wuyckhuyse BC, Pearson SK, Bowen WH. The effect of propranolol on salivary gland function and dental caries development in young and aged rats. Arch Oral Biol. 1993/10;38(10):853-61. 22. Roberts MW, Tylenda CA. Dental aspects of anorexia and bulimia nervosa. Pediatrician. 1989;16(3-4):178-84. [PMID: 2692004]. 23. Romanos GE, Javed F, Romanos EB, Williams RC. Oro-facial manifestations in patients with eating disorders. Appetite. Oct 2012;59(2):499-504. [PMID: 22750232]. 24. Chen X, Clark JJ. Tooth loss patterns in older adults with special needs: a Minnesota cohort. Int J Oral Sci. Jan 2011;3(1):27-33. [PMID: 21449213]. 25. Tannure PN, Kuchler EC, Falagan-Lotsch P, et al. MMP13 polymorphism decreases risk for dental caries. Caries Research 2012; 46(4):401-7) 26. Jones L, Ong EL, Okpokam A, Sloan P, Macleod I, Staines KS. Three cases of oral syphilis - an overview. Br Dent J. 2012;212(10):477-80. [PMID: 22627222]. 27. Czerninski R, Pikovski A, Meir K, Casap N, Moses AE, Maly A. Oral syphilis lesions--a diagnostic approach and histologic characteristics of secondary stage. Quintessence Int. Nov-Dec 2011;42(10):883-9. [PMID: 22026003]. 28. Chauhan V, Mahesh DM, Panda P, Mahajan S, Thakur S. Tuberculosis cutis orificialis (TBCO): a rare manifestation of tuberculosis. J Assoc Physicians India. Feb 2012;60:126-7. [PMID: 22715564]. 29. Sontakke SA, Umarji HR, Karjodkar F. Comparison of oral manifestations with CD4 count in HIV-infected patients. Indian J Dent Res. Sep-Oct 2011;22(5):732. [PMID: 22406727]. 30.Umoru D, Oviawe O, Ibadin M, Onunu A, Esene H. Mucocutaneous manifestation of pediatric human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) in relation to degree of immunosuppression: a study of a West African population. Int J Dermatol. Mar 2012;51(3):305-12. [PMID: 22348567]. 31. Westley S, Seymour R, Staines K. Recurrent intra-oral herpes simplex 1 infection. Dent Update. Jul-Aug 2011;38(6):368-70, 372-4. [PMID: 21905349]. 32.Terai H, Yamanishi H, Shimahara M. Nicorandil-induced tongue ulceration with or without fungal infection. Odontology. Jan 2012;100(1):100-3. [PMID: 21553069]. 33.Akin L, Herford AS, Cicciù M. Oral presentation of disseminated histoplasmosis: a case report and literature review. J Oral Maxillofac Surg. Feb 2011;69(2):535-41. 34. Garg R, Gupta VV, Ashok L. Rhinomaxillary mucormycosis: A palatal ulcer. Contemp Clin Dent. Apr 2011;2(2):119-23. [PMID: 21957389]. 35. Bonifaz A, Vázquez-González D, Macías B, Paredes-Farrera F, Hernández MA, Araiza J, et al. Oral geotrichosis: report of 12 cases. J Oral Sci. 2010/09;52(3):477-83. 36. Khatibi M, Shakoorpour A, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus. 2012;21(12):1312-5. [PMID: 22833437]. 7 37. Albilia JB, Lam DK, Clokie CM, Sándor GK. Systemic lupus erythematosus: a review for dentists. J Can Dent Assoc. Nov 2007;73(9):823-8. [PMID: 18028758]. 38.Muñoz-Corcuera M, Esparza-Gómez G, González-Moles MA, Bascones-Martínez A. Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers. Clin Exp Dermatol. 2009/06;34(4):456-61. 39. Yan Z, Hua H, Gao Y. Paraneoplastic pemphigus characterized by polymorphic oral mucosal manifestations--report of two cases. Quintessence Int. Sep 2010;41(8):689-94. [PMID: 20657859]. 40.Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. Feb 2002;46(2):207-14. [PMID: 11807431]. 41. Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn’s disease. Inflamm Bowel Dis. Feb 2010;16(2):332-7. [PMID: 19705418]. 42. Xing X, Zhang T, Wang X. Pediatric Wegener’s granulomatosis with oral ulcers and progressive periodontitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Oct 2011;112(4):e1-5. [PMID: 21868265]. 43. Noce CW, Gomes A, Copello A, Barbosa RD, Sant’anna S, Moreira MC. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent. Nov-Dec 2011;59(6):458-62; quiz 463-4. [PMID: 22313917]. 44.Brown AE, Goubran GF. Oral ulceration associated with hypothyroidism. Report of a case. Oral Surg Oral Med Oral Pathol. Aug 1978;46(2):216-9. [PMID: 280829]. 45. Beena VT, Chauhan I, Heera R, Rajeev R. Oral cancer in young non-habituè females: a report of four cases and review of the literature. Aust Dent J. 2011/09;56(3):322-7. 46. {{Ref46} Seoane-Romero JM, Vázquez-Mahía I, Seoane J, Varela-Centelles P, Tomás I, López-Cedrún JL. Factors related to late stage diagnosis of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. Jan 2012;17(1):e35-40. [PMID: 21743390]. 47.Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med. 1998;9(3):306-21. [PMID: 9715368]. 48. Wardhana, Datau EA. Recurrent aphthous stomatitis caused by food allergy. Acta Med Indones. Oct 2010;42(4):236-40. [PMID: 21063045]. 49. Basso FG, Boer CC, Corrêa ME, Torrezan M, Cintra ML, de Magalhães MH. Skin and oral lesions associated to imatinib mesylate therapy. Support Care Cancer. Apr 2009;17(4):4658. [PMID: 19037666]. 50. Al-Johani KA, Fedele S, Porter SR. Erythema multiforme and related disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. May 2007;103(5):642-54. [PMID: 17344075]. 51.Cho SB, Cho S, Bang D. New insights in the clinical understanding of Behçet’s disease. Yonsei Med J. Jan 2012;53(1):35-42. [PMID: 22187230]. 52. Karincaoglu Y, Esrefoglu M, Aki T, Mizrak B. Propylthiouracilinduced vasculitic oral ulcers with anti-neutrophil cytoplasmic antibody. J Eur Acad Dermatol Venereol. Jan 2006;20(1):1202. [PMID: 16405633]. 53.Savas N, Sevmis S, Karakayali H, Yilmaz U, Haberal M. Orogenital ulcers in a liver transplant recipient: discerning between mycophenolate-mofetil-induced complication and Behcet’s disease. Clin Transplant. 2009/03;23(2):147-9. 54.Garrigue V, Canet S, Dereure O, Panabieres O, Augias D, Chong G, et al. Oral ulcerations in a renal transplant recipient: a mycophenolate mofetil-induced complication?. Transplantation. 2001/09;72(5):968-9. 55. Pontes HA, Neto NC, Ferreira KB, Fonseca FP, Vallinoto GM, Pontes FS. Oral manifestations of vitamin B12 deficiency: a case report. J Can Dent Assoc. Sep 2009;75(7):533-7. [PMID: 19744365]. 56. Garcia BG, Cardoso MF, de Faria O, Gomez RS, Mesquita RA. A case report of pernicious anemia and recurrent aphthous stomatitis. J Contemp Dent Pract. 2009;10(2):83-9. [PMID: 19279976]. 57. Fernandes KS, Kokron CM, Barros MT, Kalil J, Gallottini M. Oral manifestations in patients with hypogammaglobulinemia. Oral Surg Oral Med Oral Pathol Oral Radiol. Sep 2012;114(3):e19-24. [PMID: 22703644]. 58. Al-Hashimi I, Drinnan AJ, Uthman AA, Wright JR, Levine MJ. Oral amyloidosis: two unusual case presentations. Oral Surg Oral Med Oral Pathol. May 1987;63(5):586-91. [PMID: 3473379]. 59. Brad W. Neville, Douglas D. DAmm, Dean K White. Color Atlas of Clinical Oral Pathology. second edition. Philadelphia.: Lippincott Williams and Wilkins; 1991. 60.Tellervo E, Matti K, Pohjamo L, Haukipuro K. Relation Between Control of Diabetes and Gingival Bleeding. Journal of Periodontology. 1985/03;56(3):154-157. 61.Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of systemic disease. Am Fam Physician. Dec 1 2010;82(11):1381-8. [PMID: 21121523]. 62. S Cortelazzo, G Finazzi, M Buelli, A Molteni, P Viero, and T Barbui. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Available at http://bloodjournal.hematologylibrary.org/ content/77/1/31.short. Accessed 10/24/12. 63.Reebye UN, Ogunrinde OA, Cottrell DA. Idiopathic thrombocytopenic purpura presenting as gingival bleeding. J Mass Dent Soc. 2003;52(2):42-3. [PMID: 12886581]. 64. Pregnancy Gingivitis (Gum Disease) and Tumors;. Available at http://www.webmd.com/oral-health/pregnancygingivitis-tumors. Accessed 10/22/12. 65. Wang PH, Chao HT, Lee WL, Yuan CC, Ng HT. Severe bleeding from a pregnancy tumor. A case report. J Reprod Med. Jun 1997;42(6):359-62. [PMID: 9219124]. 66. Boyarova TV, Dryankova MM, Bobeva AI, Genadiev GI. Pregnancy and gingival hyperplasia. Folia Med (plovid). 2001;43(1-2):53-6. 67. Singh VP, Sharma A, Sharma S. Papillon-Lefevre syndrome. Mymensingh Med J. Oct 2011;20(4):738-41. [PMID: 22081200]. 68.{{Ref68} Oral Side Effects of Medications. Available at http://www.webmd.com/oral-health/guide/oral-sideeffects-of-medications?page=2.. Accessed 10.23.12. 69.PDR for Herbal Medicines. 1st. New Jersey: Medical Economics Company; 1998. 70. Medications that affect oral health. Available at http://www. cedrugstorenews.com/userapp//lessons/page_view_ui.cf m?lessonuid=&pageid=EC0E8F0610833E8F8FB741343079 6A37. Accessed 10.23.12. 71. Nohl F, Ferrari P. [Drug-induced gingival hyperplasia]. Ther Umsch. Sep 1998;55(9):573-5. [PMID: 9789475]. 72. {{Ref72} James JA, Marley JJ, Jamal S, Campbell BA, Short CD, Johnson RW. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol. Feb 2000;27(2):109-15. [PMID: 10703656]. 73. {{Ref73} S Pradhan. Drug induced gingival enlargement – A review. Available at http://www.pmjn.org.np/index.php/ pmjn/article/view/63/53. Accessed 10/22/12. 74.{{Ref74} Harikishan G, Reddy NR, Prasad H, Anitha S. Oral Crohn’s disease without intestinal manifestations. J Pharm Bioallied Sci. Aug 2012;4(Suppl 2):S431-4. [PMID: 23066305]. 75. Balci DD, Çelik MM, Çelik E, Demir M, Yaldiz M. A rare cause of oral papillomatous lesions: Cowden syndrome. Indian J Dermatol Venereol Leprol. Mar-Apr 2012;78(2):230. [PMID: 22421679]. 76. Hmidi M, Touiheme N, Elboukhari A, Kettani M, Elmejareb 8www.ineedce.com C, Messary A. Primary B cell lymphoma of the tongue: a case report. Pan Afr Med J. 2012;12:5. [PMID: 22826730]. 77. de-Misa RF, García M, Dorta S, Febles C, Hernández-Machín B, Serrano S. Solitary oral ulceration as the first appearance of lymphomatoid papulosis: a diagnostic challenge. Clin Exp Dermatol. Mar 2010;35(2):165-8. [PMID: 19486068]. 78. Lotfi A, Moshref M, Varshosaz M, Jaberi-Ansari S, Ghafouri A. Maffucci’s syndrome with oral manifestations. Arch Iran Med. Jul 2009;12(4):421-3. [PMID: 19566364]. 79. Alajbeg I, Rogulj AA, Hutinec Z. Orofacial granulomatosis treated with intralesional triamcinolone. Acta Dermatovenerol Croat. 2011;19(3):165-9. [PMID: 21933641]. 80. Whitaker SB, Wiegand SE, Budnick SD. Intraoral molluscum contagiosum. Oral Surg Oral Med Oral Pathol. Sep 1991;72(3):334-6. [PMID: 1923422]. 81.Sciubba JJ, Niebloom T. Juvenile hyaline fibromatosis (Murray-Puretic-Drescher syndrome): oral and systemic findings in siblings. Oral Surg Oral Med Oral Pathol. Oct 1986;62(4):397-409. [PMID: 2430247]. 82. van der Beek JM, Cremers CW, van den Broek P. Successful methotrexate therapy in oral florid papillomatosis. Clin Otolaryngol Allied Sci. Dec 1980;5(6):365-71. [PMID: 7471503]. 83. Al-Azri AR, Logan RM, Goss AN. Oral Lesion as the first Clinical Presentation in Sarcoidosis: A Case Report. Oman Med J. May 2012;27(3):243-5. [PMID: 22811777]. 84. Kelner N, Rabelo GD, Perez DE, Assunção JN Jr, Witzel AL, Migliari DA. Analysis of nonspecific oral mucosal and dermal lesions suggestive of syphilis: a report of 6 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. Sep 5 2012;[PMID: 22959147]. 85. Bjekic M, Markovic M, Sipetic S. Clinical manifestations of primary syphilis in homosexual men. Braz J Infect Dis. JulAug 2012;16(4):387-9. [PMID: 22846130]. 86.Bardellini E, Amadori F, Flocchini P, Conti G, Piana G, Majorana A. Oral findings in 50 children with neurofibromatosis type 1. A case control study. Eur J Paediatr Dent. Dec 2011;12(4):256-60. [PMID: 22185252]. 87. Buchner A, Sandbank M. Multiple fibroepithelial hyperplasias of the oral mucosa. Oral Surg Oral Med Oral Pathol. Jul 1978;46(1):34-9. [PMID: 277880]. 88.Hajheydari Z, Makhlough A. Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: a study of 101 patients in Sari, Iran. Iran J Kidney Dis. Apr 2008;2(2):86-90. [PMID: 19377214]. 89. Patil S, Khaandelwal S, Doni B, Rahuman F, Kaswan S. Oral manifestations in chronic renal failure patients attending two hospitals in north karnataka, India. Oral Health Dent Manag. Sep 2012;11(3):100-6. [PMID: 22976569]. 90. } Liu ZW, Masterson LM, Srouji IA, Musonda P, Scott DG. Voice Symptoms in Patients with Autoimmune Disease: A Cross-sectional Epidemiological Study. Otolaryngol Head Neck Surg. Aug 29 2012;[PMID: 22931896]. 91. Leo M Sreebny and Arjan Vissink,. The causes of dry mouth. In: Leo M Sreebny and Arjan Vissink. Dry Mouth, The Malevolent Symptom: A Clinical Guide. 1st. Iowa.: WileyBlackwell; John Wiley and sons, inc.; 2010:Chapter 3. 92. Title: Dry Mouth – Causes. mayoclinic. Available at http:// www.mayoclinic.com/health/dry-mouth/HA00034/ DSECTION=causes. Accessed 10/24/12. 93.Dry mouth. Medicinenet. Available at http://www. medicinenet.com/dry_mouth/article.htm. Accessed 10/14/12. 94. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med. 2004;15(4):221-39. [PMID: 15284187]. 95.Asakura Y, Nishimura N, Maezawa K, Terajima T, Kizu J, Chohnabayashi N. Effect of Switching Tiotropium HandiHaler(®) to Respimat(®) Soft Mist(™) Inhaler in www.ineedce.com Patients with COPD: The Difference of Adverse Events and Usability Between Inhaler Devices. J Aerosol Med Pulm Drug Deliv. Jun 12 2012;[PMID: 22691112]. 96.Jeffrey A Burgess. Craniofacial Pain. In: Kim J Burchiel. Surgical management of pain. 1st. New York: Thieme; 2002:276-287chapter 20. 97. {Guideline} Kim Burchiel and Jeff Burgess. Facial and Cranial Pain. In: Richard B North and Robert M Levy. Neurosurgical Management of Pain. 1. 1. New York: Springer; 1997:83-99/ chapter 7. 98.Gandhi YR. Oro-mandibular dystonia. Natl J Maxillofac Surg. Jul 2010;1(2):150-2. [PMID: 22442587]. 99. Hartl DM, Cohen M, Juliéron M, Marandas P, Janot F, Bourhis J. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg. Apr 2008;138(4):459463. [PMID: 18359354]. 100.Bakke M, Møller E, Thomsen CE, Dalager T, Werdelin LM. Chewing in patients with severe neurological impairment. Arch Oral Biol. Apr 2007;52(4):399-403. [PMID: 17275777]. 101.Bakke M, Werdelin LM, Dalager T, Fuglsang-Frederiksen A, Prytz S, Møller E. Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxin. Eur J Neurol. Nov 2003;10(6):695-9. [PMID: 14641515]. 102.Pellecchia MT, Cuomo T, Striano S, Filla A, Barone P. Paroxysmal dystonia in Behçet’s disease. Mov Disord. Jan 1999;14(1):177-9. [PMID: 9918371]. 103. Ferreira-Bacci Ado V, Cardoso CL, Díaz-Serrano KV. Behavioral problems and emotional stress in children with bruxism. Braz Dent J. 2012;23(3):246-51. [PMID: 22814694]. 104.Alves Mdo S, da Silva FA, Araújo SG, de Carvalho AC, Santos AM, de Carvalho AL. Tooth wear in patients submitted to bariatric surgery. Braz Dent J. 2012;23(2):160-6. 105.Saeves R, Espelid I, Storhaug K, Sandvik L, Nordgarden H. Severe tooth wear in Prader-Willi syndrome. A case-control study. BMC Oral Health. 2012;12:12. [PMID: 22639910]. 106.Omar R, Johansson A, Johansson AK, Carlsson GE. Tooth wear. Int J Dent. 2012. 107.Young WG. The oral medicine of tooth wear. Aust Dent J. Dec 2001;46(4):236-50; quiz 306. [PMID: 11838870]. 108.Young WG, Khan F, Brandt R, Savage N, Razek AA, Huang Q. Syndromes with salivary dysfunction predispose to tooth wear: case reports of congenital dysfunction of major salivary glands, Prader-Willi, congenital rubella, and Sjögren’s syndromes. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2001;92(1):38–48. 109.Gonçalves GK, Carmagnani FG, Corrêa MS, Duarte DA, Santos MT. Dental erosion in cerebral palsy patients. J Dent Child (Chic). May-Aug 2008;75(2):117-20. [PMID: 18647505]. 110.Su JM, Tsamtsouris A, Laskou M. Gastroesophageal reflux in children with cerebral palsy and its relationship to erosion of primary and permanent teeth. J Mass Dent Soc. 2003;52(2):204. [PMID: 12886578]. 111.Dhawan VM, Sziklas JJ, Spencer RP. Localization of Ga-67 in inflammations in the absence of circulating polymorphonuclear leukocytes. J Nucl Med. Mar 1978;19(3):292-4. [PMID: 632907]. 112.Mulic A, Tveit AB, Songe D, Sivertsen H, Skaare. Dental erosive wear and salivary flow rate in physically active young adults. BMC Oral Health. 2012/03;23:12:8. 113.Tantbirojn D, Pintado MR, Versluis A, Dunn C, Delong R. Quantitative analysis of tooth surface loss associated with gastroesophageal reflux disease: a longitudinal clinical study. J Am Dent Assoc. Mar 2012;143(3):278-85. [PMID: 22383209]. 114.Mallineni SK, Yiu CK, King NM. Schwartz-Jampel syndrome: a review of the literature and case report. Spec Care Dentist. Jun 2012;32(3):105-11. [PMID: 22591433]. 115. Campos-Lara P, Santos-Diaz MA, Ruiz-Rodríguez MS, 9 Garrocho-Rangel JA, Pozos-Guillén AJ. Orofacial findings and dental management of Williams-Beuren syndrome. J Clin Pediatr Dent. 2012;36(4):401-4. [PMID: 23019840]. 116.Björksved M, Arnrup K. Homocystinuria and oral health. A report of 14 cases. Swed Dent J. 2012;36(2):101-8. [PMID: 22876397]. 117.Hattab FN. Periodontal condition and orofacial changes in patients with thalassemia major: a clinical and radiographic overview. J Clin Pediatr Dent. 2012;36(3):301-7. [PMID: 22838236]. 118.Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ. Cherubism: best clinical practice. Orphanet J Rare Dis. May 24 2012;7 Suppl 1:S6. [PMID: 22640403]. 119.Friedrich RE, Giese M, Stelljes C, Froeder C, Scheuer HA. Size of tooth crowns and position of teeth concerning the extension of facial plexiform neurofibroma in patients with neurofibromatosis type 1. Anticancer Res. May 2012;32(5):2207-14. [PMID: 22593511]. 120.Brooks JK, Bare LC, Davidson J, Taylor LS, Wright JT. Junctional epidermolysis bullosa associated with hypoplastic enamel and pervasive failure of tooth eruption: Oral rehabilitation with use of an overdenture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Apr 2008;105(4):e24-8. [PMID: 18329564]. 121.Fendrich P, Brooke RI. An unusual case of oral pigmentation. Oral Surg Oral Med Oral Pathol. Sep 1984;58(3):288-9. [PMID: 6592526]. 122.Siller GM, Tod MA, Savage NW. Minocycline-induced oral pigmentation. J Am Acad Dermatol. Feb 1994;30(2 Pt 2):3504. [PMID: 8294596]. 123.Sánchez AR, Rogers RS 3rd, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol. 2004/10;43(10):709-15. 124.Cockings JM, Savage NW. Minocycline and oral pigmentation. Aust Dent J. Feb 1998;43(1):14-6. [PMID: 9583219]. 125.Stangel I, Valdes E, Xu J. Absorption of iron by dentin: its role in discoloration. J Biomed Mater Res. Jun 1996;31(2):287-92. [PMID: 8731219]. 126.Addy M, Moran J, Griffiths AA, Wills-Wood NJ. Extrinsic tooth discoloration by metals and chlorhexidine. I. Surface protein denaturation or dietary precipitation?. Br Dent J. Nov 9 1985;159(9):281-5. [PMID: 3864472]. 127. Pontes DG, Correa KM, Cohen-Carneiro F. Reestablishing esthetics of fluorosis-stained teeth using enamel microabrasion and dental bleaching techniques. Eur J Esthet Dent. 2012;7(2):130-7. [PMID: 22645728]. 128.Swann O, Powls A. Images in clinical medicine. Green teeth in neonatal sepsis. N Engl J Med. Aug 9 2012;367(6):e8. [PMID: 22873557]. 129.Ciçek Y, Ertas U. The normal and pathological pigmentation of oral mucous membrane: a review. J Contemp Dent Pract. Aug 15 2003;4(3):76-86. [PMID: 12937598]. 130.Altunay I, Kucukunal A, Demirci GT, Ates B. Variable clinical presentations of Classic Kaposi Sarcoma in Turkish patients. J Dermatol Case Rep. Mar 27 2012;6(1):8-13. [PMID: 22514583]. 131. Shah SS, Oh CH, Coffin SE, Yan AC. Addisonian pigmentation of the oral mucosa. Cutis. Aug 2005;76(2):97-9. [PMID: 16209154]. 132.Lajolo C, Campisi G, Deli G, Littarru C, Guiglia R, Giuliani M. Langerhans’s cell histiocytosis in old subjects: two rare case reports and review of the literature. Gerodontology. Jun 2012;29(2):e1207-14. [PMID: 22612839]. 133. Pechalova P, Bakardjiev A, Zaprianov Z, Vladimirov B, Poriazova E, Zheleva A. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature. Acta Clin Croat. Jun 2011;50(2):273-9. [PMID: 22263396]. 134.Saranjam HR, Sidransky E, Levine WZ, Zimran A, Elstein D. Mandibular and dental manifestations of Gaucher disease. Oral Dis. Jul 2012;18(5):421-9. [PMID: 22251146]. 135.El Fares N, El Bouihi M, Zouhair K, El Kabli H, Benchikhi H. [Maxillary bone sarcoidosis]. Rev Stomatol Chir Maxillofac. Apr 2011;112(2):121-4. [PMID: 21429541]. 136.Ryba F, Rice S, Hutchison IL. Numb chin syndrome: an ominous clinical sign. Br Dent J. Apr 10 2010;208(7):283-5. [PMID: 20379242]. 137.Orhan E, Erol S, Deren O, Sevin A, Ekici O, Erdogan B. Idiopathic bilateral central giant cell reparative granuloma of jaws: a case report and literature review. Int J Pediatr Otorhinolaryngol. May 2010;74(5):547-52. [PMID: 20219254]. 138.Chrcanovic BR, Gomez RS, Freire-Maia B. Neurofibromatosis type 1 associated with bilateral central giant cell granuloma of the mandible. J Craniomaxillofac Surg. Oct 2011;39(7):53843. [PMID: 21071237]. 139.Srinivas C, Gupta T, Rajasekharan P, Munshi A. Bilateral mandibular metastases in medulloblastoma. J Clin Neurosci. Feb 2009;16(2):325-8. [PMID: 19056274]. 140.Cazal C, Sobral AP, Neves RF, Freire Filho FW, Cardoso AB, da Silveira MM. Oral complaints in progressive systemic sclerosis: two cases report. Med Oral Patol Oral Cir Bucal. Feb 2008;13(2):E114-8. [PMID: 18223527]. 141.Stoll ML, Sharpe T, Beukelman T, Good J, Young D, Cron RQ. Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis. J Rheumatol. Sep 2012;39(9):1880-7. [PMID: 22589268]. 142.Bracco P, Debernardi C, Piancino MG, Cirigliano MF, Salvetti G, Bazzichi L. Evaluation of the stomatognathic system in patients with rheumatoid arthritis according to the research diagnostic criteria for temporomandibular disorders. Cranio. Jul 2010;28(3):181-6. [PMID: 20806736]. 143.Farronato G, Garagiola U, Carletti V, Cressoni P, Bellintani C. Psoriatic arthritis: temporomandibular joint involvement as the first articular phenomenon. Quintessence Int. May 2010;41(5):395-8. [PMID: 20376375]. 144.Márton K. [Oral symptoms of immunologic disorders. Part I. Systemic autoimmune diseases]. Fogorv Sz. 2003/02;96(1):915. 145.Brennan MT, Patronas NJ, Brahim JS. Bilateral condylar resorption in dermatomyositis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Apr 1999;87(4):446-51. [PMID: 10225627]. 146.Maksimovskiĭ IuM, Grinin VM. [The involvement of the temporomandibular joints in systemic lupus erythematosus]. Stomatologiia (Mosk). 1995;74(2):42-5. Author Profile Jeff Burgess, DDS, MSD, (Retired) Clinical Assistant Professor, Department of Oral Medicine, University of Washington School of Dental Medicine; (Retired) Attending in Pain Center, University of Washington Medical Center; (Retired) Private Practice in Hawaii and Washington; Director, Oral Care Research Associates. He can be reached at [email protected] . Disclaimer Jeff Burgess, DDS, MSD, has no commercial ties with the sponsors or the providers of the unrestricted educational grant for this course. 10www.ineedce.com Online Completion Use this page to review the questions and answers. Return to www.ineedce.com and sign in. If you have not previously purchased the program select it from the “Online Courses” listing and complete the complete online purchase. the online Once purchase. purchased Once thepurchased exam will be theadded exam will to your be added Archives to your pageArchives where a page Take Exam wherelink a Take will Exam be provided. link willClick be provided. on the “Take ClickExam” on thelink, “Take complete Exam” link, all the complete program allquestions the program andquessubmit your tions andAn answers. submit immediate your answers. grade report An immediate will be provided grade report and upon will be receiving provided a passing and upon grade receiving your “Verification a passing grade Form”your will“Verification be providedForm” immediately will be provided for viewing immediately and/or printing. for viewing Verification and/orForms printing. can be viewed Verification and/or printed Forms anytime can be inviewed the future and/or by returning printed anytime to the site, in the sign future in and byreturn returning to your to the Archives site, sign Page. in and return to your Archives Page. Questions 1. Systemic conditions that may result in tooth discoloration include: a. Neonatal sepsis b.Hemophilia c. Thyroid disease d. Sinus disease 2.Which systemic disease may be associated with x-ray follicular space and pericoronal radiolucency: a.Tuberculosis b. Progressive systemic sclerosis c. Paget’s disease d. Pseudotumor of hemophilia 3.Name the one systemic condition that is not likely to be associated with temporomandibular joint pathology: a. Juvenile idiopathic arthritis b.Gout c.Dermatomyositis d.Cherubism 4.Which systemic condition has NOT been associated with tooth erosion: a. High blood pressure b.Obesity c.Diabetes d. Liver disease 5. Which systemic condition is NOT associated with mucosal discoloration: a.Peutz-Jegher b. Kaposi sarcoma (KS) c. Pancreatic cancer d. Laugier’s disease 6.When a patient presents with jaw muscle stiffness which of the following systemic conditions should be considered in the differential diagnosis: a.Scleroderma b. Thyroid disease c. Kidney disease d. Rheumatoid arthritis 7. Which of these systemic diseases does NOT cause unintentional jaw movement: a. Serotonin syndrome b. Substance abuse c.Epilepsy d. Jaw metastatic neoplasm 8.In a study on the relationship between dental caries and nutritional status, snack foods, and sugar-sweetened beverage consumption in schoolchildren in Thailand it was found that the following factor was strongly associated with caries development: a.Malnutrition b.Weight c. A diet of meat d. Soft drinks 9.Which one of these conditions is not associated with jaw pain: a.Tetanus b.Fibromyalgia c.Tumor d. Pancreatic disease 10. The term ‘hormonal’ gingivitis is associated with: a. Thyroid abnormality b. Adrenal insufficiency c. Pregnancy d. Pituitary disease www.ineedce.com 11. Sarcoidosis is manifested in the mouth by: a. b. c. d. Fibroepithelial hyperplasia Non-caseating granulomas Deep ulcers Blue stained gingiva 12. Which of these clinical features of oral ulcers is not helpful in defining a possible underlying systemic disease: a. Ulcer depth b. The number of ulcers c.Scaring d. Reoccurrence frequency 13. Oral ulcers that persist for a long time may be most likely to be indicative of which systemic disease: a. Kidney disease b. Thyroid disease c. Immune deficiency d.Dermatomyositis 14. Which of the following systemic conditions has not been associated with the development of dental caries: a.Diabetes b.Bulimia c. Drug abuse d. Dermatologic disease 15. Multiple painful punctuate oral ulcers occurring on the attached gingiva suggests which systemic condition: a. b. c. d. Behcet’s disease Lymphoepithelial disease Viral infection Lichen planus 16. Which of these conditions does not cause oral ulceration: a. b. c. d. Viral infection Thyroid disease Pulmonary disease Inflammatory bowel disease 17. Smokeless tobacco has been linked to what type of caries: a. b. c. d. Mesial interproximal caries Occlusal caries Cervical (root) caries Distal interproximal caries 18. A brain tumor such as a meningioma can cause: a. b. c. d. (Secondary) trigeminal neuralgia Burning tongue TMJ pain Ear pain 19. Hypogammaglobulinemia has been associated with what type of oral problem: a. Periodontal disease b.Caries c. Oral tumors d. Oral ulceration 20. In healthy patients with good oral hygiene but unusual smooth surface lesions or rampant caries what problem should be considered as a potential cause of the oral disease: a. Thyroid disease b. Pancreatic disease c.Bulimia d.Sarcoidosis 21. Heck’s disease is most likely to result in what type of oral problem: a. b. c. d. Periodontal Disease Impacted third molars Epithelial hyperplasia Gingival discoloration 22. Which class of medication is not likely to cause gingival hyperplasia: a.Corticosteroids b.Immunosuppressants c. Calcium channel blockers d. Antiepileptic drugs 23. Which systemic disease is most likely to result in post-oral ulceration scaring: a.Tuberculosis b.Syphilis c. Kidney failure d. Behcet’s disease 24. Sjogren’s disease causes what oral problem: a. b. c. d. Periodontal disease Tooth developmental abnormality Dry mouth Jaw movement abnormality 25. Large oral ulcers are most likely to be observed with which systemic disease: a. Erythema multiforma b.Herpes c. Uremic poisoning d. Aphthous stomatitis 26. Intermittent unintentional jaw movement is not likely to be associated with which one of these systemic problems: a.Dystonia b.Anorexia c. Parkinson’s disease d. Serotonin syndrome 27. Which of these intraoral problems is NOT caused by Crohn’s disease: a. b. c. d. Gingival hyperplasia Gingival bleeding Gingival erythema Gingival blackening 28. Gardner’s syndrome results in what oral problem: a. b. c. d. Periodontal bleeding Gum hyperplasia Dental malformations Mandibular osteomas 29. Multiple ulcers clustered throughout the mouth suggest what type of etiology: a. b. c. d. Kidney disease Pulmonary disease Viral infection Cardiac disease 30. In the study of caries activity of school children in Thailand, what condition besides malnutrition was found to contribute to the development of dental caries in primary teeth? a. The type of food eaten during the day b. Food intake habits at bedtime c. The number of meals eaten in a day d. The amount of food intake 11 ANSWER SHEET Oral Manifestations of Systemic Disease Name: Title: Specialty: Address:E-mail: City: State:ZIP:Country: Telephone: Home ( ) Office ( Lic. Renewal Date: ) AGD Member ID: Requirements for successful completion of the course and to obtain dental continuing education credits: 1) Read the entire course. 2) Complete all information above. 3) Complete answer sheets in either pen or pencil. 4) Mark only one answer for each question. 5) A score of 70% on this test will earn you 2 CE credits. 6) Complete the Course Evaluation below. 7) Make check payable to PennWell Corp. For Questions Call 216.398.7822 Educational Objectives If not taking online, mail completed answer sheet to Academy of Dental Therapeutics and Stomatology, 1. Discuss the complexity of the relationship between systemic disease and various oral conditions. A Division of PennWell Corp. 2. Identify the different oral manifestations associated with specific systemic diseases. P.O. Box 116, Chesterland, OH 44026 or fax to: (440) 845-3447 3. Differentiate between potential systemic diseases associated with some specific oral conditions such as ulceration. 4. Have improved diagnostic skills in relation to the connection between systemic disease and oral pathology. For immediate results, go to www.ineedce.com and click on the button “Take Tests Online.” Answer sheets can be faxed with credit card payment to (440) 845-3447, (216) 398-7922, or (216) 255-6619. Course Evaluation 1. Were the individual course objectives met?Objective #1: Yes No Objective #2: Yes No Objective #3: Yes No Objective #4: Yes No P ayment of $49.00 is enclosed. (Checks and credit cards are accepted.) Please evaluate this course by responding to the following statements, using a scale of Excellent = 5 to Poor = 0. 2. To what extent were the course objectives accomplished overall? 5 4 3 2 1 0 If paying by credit card, please complete the following: MC Visa AmEx Discover 3. Please rate your personal mastery of the course objectives. 5 4 3 2 1 0 Acct. Number: ______________________________ 4. How would you rate the objectives and educational methods? 5 4 3 2 1 0 Exp. Date: _____________________ 5. How do you rate the author’s grasp of the topic? 5 4 3 2 1 0 6. Please rate the instructor’s effectiveness. 5 4 3 2 1 0 7. Was the overall administration of the course effective? 5 4 3 2 1 0 8. Please rate the usefulness and clinical applicability of this course. 5 4 3 2 1 0 9. Please rate the usefulness of the supplemental webliography. 4 3 2 1 0 5 10. Do you feel that the references were adequate? Yes No 11. Would you participate in a similar program on a different topic? Yes No Charges on your statement will show up as PennWell 12. If any of the continuing education questions were unclear or ambiguous, please list them. ___________________________________________________________________ 13. Was there any subject matter you found confusing? Please describe. ___________________________________________________________________ ___________________________________________________________________ 14. How long did it take you to complete this course? ___________________________________________________________________ ___________________________________________________________________ 15. What additional continuing dental education topics would you like to see? ___________________________________________________________________ ___________________________________________________________________ AGD Code 739 PLEASE PHOTOCOPY ANSWER SHEET FOR ADDITIONAL PARTICIPANTS. COURSE EVALUATION and PARTICIPANT FEEDBACK We encourage participant feedback pertaining to all courses. Please be sure to complete the survey included with the course. Please e-mail all questions to: [email protected]. INSTRUCTIONS All questions should have only one answer. Grading of this examination is done manually. Participants will receive confirmation of passing by receipt of a verification form. Verification of Participation forms will be mailed within two weeks after taking an examination. COURSE CREDITS/COST All participants scoring at least 70% on the examination will receive a verification form verifying 2 CE credits. The formal continuing education program of this sponsor is accepted by the AGD for Fellowship/ Mastership credit. Please contact PennWell for current term of acceptance. Participants are urged to contact their state dental boards for continuing education requirements. PennWell is a California Provider. The California Provider number is 4527. The cost for courses ranges from $20.00 to $110.00. Provider Information PennWell is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, not does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE Provider may be directed to the provider or to ADA CERP ar www.ada. org/cotocerp/ The PennWell Corporation is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing dental education programs of this program provider are accepted by the AGD for Fellowship, Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from (11/1/2011) to (10/31/2015) Provider ID# 320452 RECORD KEEPING PennWell maintains records of your successful completion of any exam for a minimum of six years. Please contact our offices for a copy of your continuing education credits report. This report, which will list all credits earned to date, will be generated and mailed to you within five business days of receipt. Completing a single continuing education course does not provide enough information to give the participant the feeling that s/he is an expert in the field related to the course topic. It is a combination of many educational courses and clinical experience that allows the participant to develop skills and expertise. CANCELLATION/REFUND POLICY Any participant who is not 100% satisfied with this course can request a full refund by contacting PennWell in writing. Image Authenticity The images provided and included in this course have not been altered. © 2013 by the Academy of Dental Therapeutics and Stomatology, a division of PennWell OMSD713DIG Customer Service 216.398.7822